Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (956)	6/23/1999 8:37:00 PM
From: Dutch	Read Replies (1) \| Respond to of 965

I am biased, but from what I understand Isis is can't keep up with Rimicade. Rimicade is also about to get approval for arthiritis: XXX times the patient population. They now have a little known variance from the FDA to market Rimicade RA patients. OT Morgan Stanley/DW has 2002 E/Share of $6-8/share; 50xE=$300-400/share. I am not the only nut, there are some who believe that with digital ph, HDTV, Games and a multitude of other app's we are looking at much greater earnings and P/E. Go to RMBS message board and look foe unclewest for bull and Don Green for bear comments. You can book mark them and research post. Thx. Dutch PS: look at Scumbria, tends to be a techy in the middle